Delivery Order SPE2DB20D2104-SPE2DB23FR67C
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies, including Myrbetriq ER 50 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $8,059.89, is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Cencora, Inc. with the DLA. This IDC serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Myrbetriq ER 50 mg tablets. The $9,734.19 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $76,500.49 delivery order contract is for the supply of Myrbetriq ER 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $89,936.54, is for the delivery of Myrbetriq ER 25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,252.01 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,106.98 fixed-price delivery order is for the drug Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of January 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 through November 2026. The IDC enables the DLA to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,892.80, is for the delivery of 90 tablets of the prescription medication Myrbetriq ER 50 mg. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Myrbetriq ER 25 mg tablets. The $2,250.23 firm-fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $44,070.47 for the provision of the pharmaceutical product Myrbetriq ER 50 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies, including Myrbetriq ER 25 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $27,649.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR67CDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,025.35 firm fixed-price delivery order is for the medication Myrbetriq ER 50 mg tablet, with a completion date of January 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. This contract award demonstrates Amerisourcebergen's role as a critical supplier of essential medications and medical commodities to the U.S. federal government, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 1/5/23 |